CTRI/2024/03/063613
Not yet recruiting
Phase 4
A Comparative study to evaluate the efficacy and safety of topical Luliconazole versus topical Ciclopirox olamine among patients with Tinea corporis/cruris - NI
Pradeep0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Sponsor
- Pradeep
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Patients willing to give informed consent and follow up.
- •2\)Patients of either gender aged between 18\-60 years.
- •2\)Patients with mild Tinea corporis or cruris and Positive KOH Test.
Exclusion Criteria
- •1\)Patients with hypersensitivity to study medications.
- •2\)Patients with deep fungal infections.
- •3\)Patients with Tinea unguim, Tinea capitis and Tinea barbae.
- •4\)Psychiatric or emotional disturbance in patients.
- •5\)Diabetic and Immunocompromised patients.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
A study to compare the effectiveness and safety of bempedoic acid and ezetimibe for treating high lipid levelsCTRI/2024/07/070838Afzal Noor
Not yet recruiting
Phase 4
Efficacy of oral tranexamic acid and topical triple combination cream in treatment of melasmaHealth Condition 1: L814- Other melanin hyperpigmentationCTRI/2024/04/065382MOHAN H
Not yet recruiting
Not Applicable
Comparison of efficacy and safety of Vortioxetine and Escitalopram in depressive patients.Health Condition 1: F321- Major depressive disorder, singleepisode, moderateCTRI/2023/12/060661Ronakkumar Chandubhai Patel
Not yet recruiting
Not Applicable
Iron deficiency anemia treatment in adults: comparing daily versus alternate day iron regimensCTRI/2024/03/064861Viswanathan S
Not yet recruiting
Not Applicable
A study to compare two drugs Seratconazole versus Luliconacole for improvement of symptoms and to compare the side effectsHealth Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecifiedHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2022/10/046157Yuvarani R